Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Resist the Urge to Give Nesiritide

By ACEP Now | on May 1, 2011 | 0 Comment
Opinion
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

As a shareholder of common stock in Johnson and Johnson (J&J), the parent company of Scios (the company that markets nesiritide), I guess I should have been happy to read the headline “Trial: Nesiritide Safe for Acute Heart Failure” in the January 2011 ACEP News.

You Might Also Like
  • The Role of Nesiritide
  • ACEP15 Session: Time-Critical Interventions in Treating Heart Failure
  • Update Your Knowledge on Heart Failure Assessment and Treatment
Explore This Issue
ACEP News: Vol 30 – No 05 – May 2011

However, as a physician who wants to do what is best for his patients, I must cynically ask why the headline did not read “Nesiritide: It May Not Do Any Good, but At Least It Won’t Kill the Patient or Their Kidneys.”

The story indicated that when a patient has acute decompensated heart failure, after trying nitrates and/or nitroprusside as vasodilators, as well as loop diuretics, at least nesiritide appears to not increase mortality or harm renal function when it is given to patients who are not already hypotensive.

I am troubled that the story made no mention of the efficacy of positive airway pressure techniques, nor of the fact that positive pressure provided with endotracheal intubation, while not without risks, can improve oxygenation and ventilation of patients with acute decompensated heart failure.

I am also concerned that this story will be used by some, such as the three physicians quoted in the story (Dr. Hernandez, Dr. Califf, and Dr. Jessup, all of whom have received financial support from either J&J or Scios) to attempt to justify expensive, noneffective treatment for a fairly frequent emergency condition. (I commend ACEP News for noting the fact that all three of these doctors had a potential conflict of interest as regards nesiritide.)

Sometimes the most difficult but most appropriate thing for a doctor to do is to resist the temptation to “just do something.” Doctors like to be able to order a drug and monitor for hoped-for effects. Unfortunately, as regards nesiritide, the best thing for doctors to do is to resist the urge to give a nonefficacious drug and look to the assistance of their respiratory therapist rather than to an ineffective pharmaceutical.

Gary M. Gaddis, M.D.
Kansas City, Mo.

Topics: ACEPAirway ManagementAmerican College of Emergency PhysiciansCardiovascularConflict of InterestCost of Health CareCritical CareEmergency MedicineEmergency PhysicianLettersPatient SafetyPharmaceuticalsPulmonaryQuality

Related

  • July 2025 News from the College

    July 2, 2025 - 0 Comment
  • Push-Dose Pressors in the Emergency Department

    June 29, 2025 - 1 Comment
  • ACEP Clinical Policy on Outpatient Mgmt. of Adults with Asymptomatic Elevated Blood Pressure

    June 25, 2025 - 0 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

About the Author

ACEP Now

View this author's posts »

No Responses to “Resist the Urge to Give Nesiritide”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603